Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Gynecologic Oncology|February 9, 2021
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in SingaporeDavid Sp Tan, Jack Junjie Chan, Robert Hettle, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|April 23, 2013
A large tuberculosis abscess causing spinal cord compression of the cervico-thoracic region in a young childS R Manoharan, J Leitao, P Emberton, et al.
Journal of Gynecologic Oncology|July 24, 2025
Clinical and biological characteristics associated with of loss-of-heterozygosity in endometrial cancerFelix Blanc-Durand, Etienne Rouleau, Patricia Pautier, et al.
Journal of Gynecologic Oncology|February 9, 2021
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)Yong Jae Lee, Myong Cheol Lim, Byoung Gie Kim, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Nature Communications|September 6, 2023
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4Yoo-Na Kim, Boram Park, Jae Weon Kim, et al.
The Journal of Pathology|July 29, 2021
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinomaValerie Heong, Tuan Z Tan, Maiko Miwa, et al.
Journal of Gynecologic Oncology|April 12, 2024
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experienceSilvana Talisa Wijaya, Natalie Yl Ngoi, Jerold Wz Loh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2020
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)Natalie Yl Ngoi, Valerie Heong, Samuel Ow, et al.
Cancers|June 21, 2020
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous TechniqueValerie Heong, Darwin Tay, Shane Ee Goh, et al.
Pageof 3